Latest News in the pharma Industry

Top Stories

Pfizer Signs Licensing Agreement with Puma

Pfizer Signs Licensing Agreement with Puma

8 Oct 2011

Puma Biotechnology will assume sole responsibility for global development and commercialization of neratinib which is being studied for the treatment of cancer.

Read more 
Merck Chairman to Retire in December

Merck Chairman to Retire in December

8 Oct 2011

Merck & Co.'s former CEO, Richard T. Clark, is retiring as chairman effective December 1st.

Read more 
Evotec Forms Drug Discovery Collaboration with UCB

Evotec Forms Drug Discovery Collaboration with UCB

8 Oct 2011

Evotec AG has entered into a multi-target drug discovery collaboration with UCB in the field of immunology.

Read more 
Takeda Completes Acquisition of Nycomed

Takeda Completes Acquisition of Nycomed

5 Oct 2011

Osaka-based Takeda hopes the addition of the Swiss firm will boost Takeda's sales by approximately 30% and move the company to 12th in the pharmaceutical sales table.

Read more 
Rexahn Completes Patient Recruitment in Cancer Drug Trial

Rexahn Completes Patient Recruitment in Cancer Drug Trial

4 Oct 2011

Rexahn Pharmaceuticals has completed enrollment for a Phase II clinical trial of its experimental cancer drug Archexin.

Read more 
Evotec Takes over Full Ownership of JV in India

Evotec Takes over Full Ownership of JV in India

30 Sep 2011

Evotec has agreed to acquire the remaining 30% of its Joint Venture with DIL Ltd., India for $2.3 million.

Read more 
NIBRT Collaborates with GE Healthcare for Novel Analytical Platforms

NIBRT Collaborates with GE Healthcare for Novel Analytical Platforms

29 Sep 2011

The collaboration aims to develop new, robust and reproducible biochemical assays for the analysis of the biological activity of therapeutic monoclonal antibodies.

Read more 
Japan's Santen to Acquire French Novagali

Japan's Santen to Acquire French Novagali

29 Sep 2011

Japanese drugmaker Santen Pharmaceutical said on Wednesday it has agreed to buy 50.55 percent of French biopharma Novagali.

Read more 
Helsinn Healthcare & Riemser Arzneimittel Expand Licensing Agreement

Helsinn Healthcare & Riemser Arzneimittel Expand Licensing Agreement

29 Sep 2011

Helsinn Healthcare and Riemser Arzneimittel signed an agreement to grant marketing rights in Germany to Riemser for a next-generation treatment in development for the prevention of chemotherapy-induced nausea and vomiting.

Read more 
AmerisourceBergen to Acquire TheraCom for $250M

AmerisourceBergen to Acquire TheraCom for $250M

28 Sep 2011

Pharmaceutical wholesaler AmerisourceBergen has agreed to buy TheraCom, a subsidiary of CVS Caremark, for $250 million.

Read more 
Biotie Therapies to Acquire Newron for €45M

Biotie Therapies to Acquire Newron for €45M

28 Sep 2011

Finnish biotech Biotie Therapies will purchase Italian biopharmaceutical firm Newron Pharmaceuticals for €45m.

Read more 
Lonza & Mesoblast Ink Manufacturing Pact for Stem Cell Products

Lonza & Mesoblast Ink Manufacturing Pact for Stem Cell Products

28 Sep 2011

Lonza has entered into a strategic alliance with Australia-based Mesoblast for the production of Mesoblast's adult stem cell therapies.

Read more